CHRONIC MYELOID LEUKEMIA
Clinical trials for CHRONIC MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can CML patients pause treatment? new study explores Drug-Free remission
Disease control TerminatedThis study looked at 124 adults with chronic myeloid leukemia (CML) who had been on the drug nilotinib for at least 3 years and had very low levels of cancer. First, researchers tested if lowering the nilotinib dose by half for a year could help patients stop treatment entirely. …
Matched conditions: CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
CML drug combo aims for Treatment-Free remission, but trial stalls
Disease control TerminatedThis phase 3 trial tested whether adding asciminib to the standard drug imatinib could help people with chronic myeloid leukemia (CML) achieve a deep remission and safely stop all medication. Only 8 patients were enrolled before the study was terminated early, making it too small…
Matched conditions: CHRONIC MYELOID LEUKEMIA
Phase: PHASE3 • Sponsor: Sarit Assouline • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Blood pressure drug tested to prevent transplant complication
Prevention TerminatedThis pilot study tested the blood pressure drug telmisartan (Micardis) to prevent acute graft-versus-host disease (GVHD) in people receiving a stem cell transplant for blood cancers. The trial aimed to enroll 60 participants but was terminated early with 32. Researchers tracked s…
Matched conditions: CHRONIC MYELOID LEUKEMIA
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC